-+ 0.00%
-+ 0.00%
-+ 0.00%

AKESO - CHINA NMPA APPROVES IVONESCIMAB PLUS CHEMOTHERAPY FOR FIRST-LINE ADVANCED SQUAMOUS NSCLC

Reuters·08/12/2026 12:18:33

Please log in to view news